Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation - Bain Capital
  Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn - Pharmaceutical Technology
  Blackstone, Bain to bid for Mitsubishi pharma unit in up to $3.5 bln deal, sources say - Reuters
  GV20 Therapeutics Announces Collaboration Agreement with Mitsubishi Tanabe Pharma Corporation to Develop Novel Antibody-Drug Conjugates - PR Newswire
  Bain throws down $3.3B to acquire Japan's Mitsubishi Tanabe Pharma - Fierce Pharma
  Bain buys Mitsubishi pharma unit; Bausch + Lomb deal talks come up empty - BioPharma Dive
  SparX teams with Mitsubishi Tanabe on novel ADC project - The Pharma Letter
  Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe Pharma - MedCity News